×
0 0 0 0 0 0.00810044552450382 -0.00364520048602673 -0.00769542324827871
Stockreport

TG Therapeutics, Inc. Announces Clinical Data Presentations at the Upcoming 14th International Conference on Malignant Lymphoma

TG THERAPEUTICS (TGTX)  More Company Research Source: GlobeNewswire
Last tg therapeutics earnings: 8/7 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.tgtherapeutics.com
PDF NEW YORK, June 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that clinical abstracts featuring TG-1101 and TGR-1202 have been selected for presentation at the upcoming 14th International Conference on Malignant Lymphoma (ICML), to be held from June 14 - 17, 2017, in Lugano, Switzerland. The abstracts were made public yesterday, and are included in the Abstract Book available through the ICML meeting website at www.lymphcon.ch. Details of the data presentations are outlined below. Oral Presentations: Title: Updated results of a multicenter phase I/Ib study of TGR-1202 in combination with ibrutinib in patients with relapsed or refractory MCL or CLL Abstract Number: 040Presentation Date & Time: Wednesday, June 14, 2017 17:50 CESTSession Title: Chemotherapy-Free CombinationsPresenter: Matthew S. Davids, MD, Dana-Farber Cancer Institute Title: Ublituximab and ibrutinib for previously treated genetically high-risk chronic lymphocytic leukemia: Resu [Read more]

IMPACT SNAPSHOT EVENT TIME: TGTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS